| Summary: | <p>Abstract</p> <p>Background</p> <p>To construct the <it>Bifidobacterium infantis</it>-mediated soluble kinase insert domain receptor (sKDR) prokaryotic expression system and to observe its inhibitory effect on growth of human umbilicus vessel endothelial cells (HUVECs) <it>in vitro</it> and Lewis lung cancer (LLC) on mice <it>in vivo.</it></p> <p>Methods</p> <p>The <it>Bifidobacterium infantis</it>-mediated sKDR prokaryotic expression system was constructed through electroporation and subsequently identified through PCR and Western blot analysis. HUVECs were added to the products of this system to evaluate the anti-angiogenesis effect through MTT assay <it>in vitro</it>. The LLC mice models were divided into three groups: one group treated with saline (group a); one group treated with recombinant <it>Bifidobacterium infantis</it> containing pTRKH2-PsT plasmid group (group b); and one group treated with recombinant <it>Bifidobacterium infantis</it> containing pTRKH2-PsT/sKDR plasmid group (group c). The quality of life and survival of mice were recorded. Tumor volume, tumor weight, inhibitive rate, and necrosis rate of tumor were also evaluated. Necrosis of tumor and signals of blood flow in tumors were detected through color Doppler ultrasound. In addition, microvessel density (MVD) of the tumor tissues was assessed through CD31 immunohistochemical analysis.</p> <p>Results</p> <p>The positively transformed <it>Bifidobacterium infantis</it> with recombinant pTRKH2-PsT/sKDR plasmid was established, and was able to express sKDR at gene and protein levels. The proliferation of HUVECs cultivated with the extract of positively transformed bacteria was inhibited significantly compared with other groups (P < 0. 05). The quality of life of mice in group c was better than in group a and b. The recombinant <it>Bifidobacterium infantis</it> containing pTRKH2-PsT/sKDR plasmid enhanced the efficacy of tumor growth suppression and prolongation of survival, increased the necrosis rate of tumor significantly, and could obviously decrease MVD and the signals of blood flow in tumors.</p> <p>Conclusion</p> <p>The <it>Bifidobacterium infantis</it>-mediated sKDR prokaryotic expression system was constructed successfully. This system could express sKDR at gene and protein levels and significantly inhibit the growth of HUVECs induced by VEGF <it>in vitro</it>. Moreover, it could inhibit tumor growth and safely prolong the survival time of LLC C57BL/6 mice.</p>
|
|---|
